Scarica l'app Stockscreener
142.34
1.51%
-2.405
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché A Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$144.75
Aprire:
$142.58
Volume 24 ore:
148.07K
Relative Volume:
0.07
Capitalizzazione di mercato:
$40.13B
Reddito:
$7.23B
Utile/perdita netta:
$1.41B
Rapporto P/E:
28.59
EPS:
4.979
Flusso di cassa netto:
$1.09B
1 W Prestazione:
-4.95%
1M Prestazione:
-4.14%
6M Prestazione:
+23.50%
1 anno Prestazione:
+14.86%
Intervallo 1D:
$141.25
$144.15
Intervallo di 1 settimana:
$141.25
$151.59
Portata 52W:
$108.35
$163.75
Agilent Technologies Inc Stock (A) Company Profile
Nome
Agilent Technologies Inc
Settore
Industria
Telefono
(408) 345-8886
Indirizzo
5301 STEVENS CREEK BLVD, SANTA CLARA, CA
Compare A vs TMO, DHR, NTRA, IQV, IDXX
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
A
Agilent Technologies Inc
|
142.34 | 40.81B | 7.23B | 1.41B | 1.09B | 4.979 |
TMO
Thermo Fisher Scientific Inc
|
600.87 | 223.95B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
201.54 | 144.01B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
328.92 | 47.61B | 2.50B | -226.32M | 71.51M | -1.6412 |
IQV
Iqvia Holdings Inc
|
253.86 | 42.30B | 16.63B | 1.39B | 2.12B | 8.0674 |
IDXX
Idexx Laboratories Inc
|
512.15 | 40.58B | 4.45B | 1.10B | 1.06B | 13.59 |
Agilent Technologies Inc Stock (A) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-20 | Iniziato | HSBC Securities | Buy |
| 2026-01-05 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2025-12-15 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2025-12-09 | Iniziato | Goldman | Buy |
| 2025-12-02 | Iniziato | Morgan Stanley | Overweight |
| 2025-10-08 | Iniziato | Rothschild & Co Redburn | Buy |
| 2025-10-08 | Aggiornamento | UBS | Neutral → Buy |
| 2025-02-10 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2024-08-28 | Iniziato | Wells Fargo | Overweight |
| 2024-07-10 | Aggiornamento | Citigroup | Neutral → Buy |
| 2024-06-27 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2024-06-03 | Ripresa | Jefferies | Hold |
| 2024-04-05 | Aggiornamento | Stifel | Hold → Buy |
| 2023-12-13 | Iniziato | Wolfe Research | Outperform |
| 2023-12-12 | Downgrade | BofA Securities | Buy → Neutral |
| 2023-11-17 | Downgrade | UBS | Buy → Neutral |
| 2023-09-28 | Iniziato | Bernstein | Mkt Perform |
| 2023-07-31 | Downgrade | Evercore ISI | Outperform → In-line |
| 2023-05-24 | Reiterato | Barclays | Equal Weight |
| 2023-05-24 | Reiterato | BofA Securities | Buy |
| 2023-05-24 | Reiterato | Citigroup | Neutral |
| 2023-05-24 | Reiterato | Credit Suisse | Outperform |
| 2023-05-24 | Reiterato | Evercore ISI | Outperform |
| 2023-05-24 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-05-24 | Reiterato | Robert W. Baird | Outperform |
| 2023-05-24 | Reiterato | SVB Securities | Outperform |
| 2023-05-24 | Reiterato | Stifel | Hold |
| 2023-05-24 | Reiterato | TD Cowen | Outperform |
| 2023-05-24 | Reiterato | Wells Fargo | Overweight |
| 2023-05-11 | Iniziato | Barclays | Equal Weight |
| 2023-01-10 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2022-08-25 | Iniziato | Credit Suisse | Outperform |
| 2022-07-20 | Iniziato | UBS | Buy |
| 2022-07-08 | Downgrade | Citigroup | Buy → Neutral |
| 2022-04-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2022-02-23 | Reiterato | BofA Securities | Buy |
| 2022-02-23 | Reiterato | Citigroup | Buy |
| 2022-02-23 | Reiterato | Cowen | Outperform |
| 2022-02-23 | Reiterato | Evercore ISI | Outperform |
| 2022-02-23 | Reiterato | Stifel | Hold |
| 2022-02-23 | Reiterato | Wells Fargo | Overweight |
| 2021-11-23 | Reiterato | BofA Securities | Buy |
| 2021-11-23 | Reiterato | Cowen | Outperform |
| 2021-11-23 | Reiterato | Stifel | Hold |
| 2021-03-18 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-02-17 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2020-12-02 | Iniziato | Goldman | Buy |
| 2020-11-25 | Aggiornamento | UBS | Neutral → Buy |
| 2020-11-17 | Aggiornamento | Cleveland Research | Neutral → Buy |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2020-09-30 | Iniziato | Atlantic Equities | Neutral |
| 2020-08-19 | Reiterato | BofA Securities | Neutral |
| 2020-08-19 | Reiterato | Citigroup | Neutral |
| 2020-08-19 | Reiterato | Jefferies | Buy |
| 2020-08-19 | Reiterato | Robert W. Baird | Outperform |
| 2020-08-19 | Reiterato | SVB Leerink | Outperform |
| 2020-08-19 | Reiterato | Stifel | Hold |
| 2020-08-19 | Reiterato | Wells Fargo | Overweight |
| 2020-02-24 | Downgrade | Needham | Buy → Hold |
| 2020-01-08 | Iniziato | Wells Fargo | Overweight |
| 2020-01-07 | Iniziato | Citigroup | Neutral |
| 2019-11-26 | Reiterato | Needham | Buy |
| 2019-11-15 | Iniziato | Stifel | Hold |
| 2019-10-18 | Downgrade | UBS | Buy → Neutral |
| 2019-07-16 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2019-07-15 | Downgrade | Barclays | Overweight → Equal Weight |
Mostra tutto
Agilent Technologies Inc Borsa (A) Ultime notizie
Agilent director Mikael Dolsten sells 634 shares for USD 95,980.75 - Bitget
Agilent Technologies Director Mikael Dolsten Reports Sale of 634 Shares - Kalkine Media
Agilent Technologies stock holds near 52-week high after guidance lift - ad-hoc-news.de
Agilent Technologies Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Agilent Technologies Shares Fall After UBS Downgrade - marketscreener.com
UBS Downgrades Agilent Technologies to Neutral From Buy, $165 Price Target - Moomoo
Agilent Technologies (NYSE: A) Announces 2027 Board Leadership Changes with New Chair and Director - Kalkine Media
Agilent appoints new board chair and independent director - The Globe and Mail
Agilent Technologies Announces Board Chair Retirement and New Director Appointment - Kalkine Media
Agilent names Dow Wilson board chair after Koh Boon Hwee retires - Bitget
Agilent Names Dow Wilson Board Chair, Adds Former Stryker CFO Glenn Boehnlein - citybiz
Agilent Technologies Inc. Announces Board Changes, Effective September 4, 2026 - marketscreener.com
Agilent names new board chair, adds director By Investing.com - Investing.com Canada
Agilent names new board chair, adds director - Investing.com
Ex-Stryker finance chief joins Agilent (NYSE: A) board as chair role shifts - Stock Titan
Agilent Announces Retirement of Board Chair Koh Boon Hwee, Appointment of Glenn Boehnlein to Board of Directors - Business Wire
Agilent Technologies stock gains on digital pathology launch and raised 2026 outlook - ad-hoc-news.de
Agilent (A) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance
Agilent Technologies, Inc. (A) Investor Outlook: Analyzing a 16.30% Potential Upside in the Diagnostics Sector - DirectorsTalk Interviews
Price to sales forward of Agilent Technologies, Inc. – MIL:1A - TradingView
Agilent Technologies stock gains as FDA-cleared S540MD slide scanner strengthens digital pathology p - ad-hoc-news.de
Agilent Technologies | 144: Notice of proposed sale of securities pursuant to Rule 144 - Moomoo
Mikael Dolsten to sell Agilent (NYSE: A) stock - Stock Titan
Worker says Agilent fired him to mask race and age bias - hcamag.com
Agilent Technologies stock gains on digital pathology launch and strong Q3 figures - AD HOC NEWS
Agilent Expands Digital Pathology Offering with U.S. Launch of the Agilent S540MD Slide Scanner System - 01net
Agilent Technologies Launches FDA-Cleared S540MD Slide Scanner in US - marketscreener.com
Agilent launches FDA-cleared slide scanner in U.S. market - Investing.com
Agilent launches FDA-cleared slide scanner in U.S. market By Investing.com - Investing.com Australia
Global Multiplex Assays Market 2026 Edition - GlobeNewswire Inc.
Agilent launches new ICP-MS, GC Systems and Digital Lab Execution platform in India - indianpharmapost.com
Baird Adjusts Price Target on Agilent Technologies to $180 From $169, Keeps Outperform Rating - marketscreener.com
Agilent Unveils Next‑Gen Lab Technologies to Boost India’s Testing Efficiency and Compliance - Indianweb2.com
Agilent Technologies Inc (A) Looks 2.6% Overvalued on GF Value™ - GuruFocus
Agilent: The Recovery Is Real, But So Is The Valuation (NYSE:A) - Seeking Alpha
A SWOT Analysis: Agilent Technologies Inc (A) Reveals Financial Insights in 10-Q Filing - GuruFocus
Bond swap: Agilent (NYSE: A) offers to exchange $600M in 4.9% notes - Stock Titan
Agilent (NYSE: A) readies global debt program with $100M default triggers - Stock Titan
Agilent Technologies 3Q 2026: Revenue $1.88B, EPS $1.28— 10-Q Summary - TradingView
Agilent (NYSE: A) spends $950M on Biocare — see how Q3 earnings and debt shifted - Stock Titan
Tranche Update on Agilent Technologies, Inc. (NYSE:A)'s Equity Buyback Plan announced on May 29, 2024. - marketscreener.com
Agilent Technologies stock rises on Q3 beat and guidance - AD HOC NEWS
Agilent Introduces the Cary 635 FTIR Spectrometer - Business Wire
Agilent Technologies, Inc. Introduces The Cary 635 FTIR Spectrometer - marketscreener.com
Agilent launches Cary 635 FTIR spectrometer for laboratories - Investing.com
HSBC Adjusts Price Target on Agilent Technologies to $175 From $165, Maintains Buy Rating - marketscreener.com
AGILENT TECHNOLOGIES INC : HSBC RAISES TARGET PRICE TO $175 FROM $165 - Bitget
International Markets and Agilent (A): A Deep Dive for Investors - Yahoo Finance
Weekly Recap: Agilent (A) Q3 results and pharma reshoring opportunity - TradingView
Agilent Technologies, Inc. (A) Stock Analysis: Exploring a 13.36% Potential Upside in the Diagnostics & Research Sector - DirectorsTalk Interviews
Stronger Q3 Results and Raised Guidance Could Be A Game Changer For Agilent Technologies (A) - Sahm
Agilent Technologies Inc Azioni (A) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.04%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):